Victory Capital Management
BVS icon

Victory Capital Management’s Bioventus BVS Stock Holding History

Victory Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$698K Buy
73,993
+12,298
+20% +$117K ﹤0.01% 2006
2026
Q1 		$563K Sell
61,695
-5,017
-8% -$42.1K ﹤0.01% 2006
2025
Q4 		$496K Buy
66,712
+11,663
+21% +$83.8K ﹤0.01% 2019
2025
Q3 		$368K Buy
55,049
+9,843
+22% +$68.3K ﹤0.01% 2109
2025
Q2 		$299K Buy
+45,206
New +$321K ﹤0.01% 2161
2022
Q4 		– Sell
-40,421
Closed -$283K – 2603
2022
Q3 		$283K Sell
40,421
-3,326
-8% -$26K ﹤0.01% 2265
2022
Q2 		$298K Buy
43,747
+20,539
+88% +$210K ﹤0.01% 2240
2022
Q1 		$279K Buy
+23,208
New +$311K ﹤0.01% 2322

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management's BVS Position: Q2 2026 in Review

Victory Capital Management increased its Bioventus (BVS) stake by 20% in Q2 2026, buying an estimated $117K and bringing the position to 73,993 shares worth $698K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

Victory Capital Management first reported a position in BVS in Q1 2022 and has held it in 8 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Victory Capital Management held 73,993 shares of Bioventus worth $698K as of Q2 2026.
  • Victory Capital Management bought 12,298 Bioventus shares in Q2 2026, an estimated $117K.
  • Bioventus made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2006 holding.
  • Victory Capital Management first reported a position in Bioventus in Q1 2022 and has held it in 8 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.